acceso

man-working-as-pharmacist

Good Regulatory Practices: principles that transform global health

1727902526469

61° Consejo Directivo de la OPS: Acceso y uso racional de medicamentos estratégicos y de alto costo y otras tecnologías de salud

pexels-julie-viken-593451

What is the waiting time to access new cancer medications in Latin America?

Smiling Cancer Patient Looking at test results

FIFARMA launches the second version of the W.A.I.T. Indicator Survey measuring the waiting time to access innovative drugs in LATAM

Pasquale Frega_LACanIMI President

Universal access to health will only be possible and sustainable if innovation is a key driver

pexels-pixabay-40568

Equitable access to cancer care and treatment, a major health challenge in Latin America

Search

Recent posts

Estudo FIFARMA W.A.I.T. Indicator 2026 sobre o acesso à inovação na América Latina
FIFARMA W.A.I.T. Indicator 2026: do tempo de espera à oportunidade de avançar
FIFARMA W.A.I.T. Indicator 2026 study on access to innovation in Latin America
FIFARMA W.A.I.T. Indicator 2026: from waiting time to an opportunity to move forward
Estudio FIFARMA W.A.I.T. Indicator 2026 sobre el tiempo de acceso a medicamentos innovadores en América Latina.
FIFARMA W.A.I.T. Indicator 2026: del tiempo de espera a la oportunidad de avanzar